Advertisement
Screener

Asensus Surgical, Inc. Net Change in Cash

Asensus Surgical, Inc. Net Change in Cash

Asensus Surgical, Inc. reported Net Change in Cash of -$9.44 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2024-08-13

  • Asensus Surgical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$10.26M, a 182.68% decline year-over-year.
  • Asensus Surgical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $12.41M, a 84.63% increase year-over-year.
  • Asensus Surgical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was $6.72M, a 95.49% decline year-over-year.
  • Asensus Surgical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $148.87M, a 1122.81% increase year-over-year.
  • Asensus Surgical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $11.27M.
  • Asensus Surgical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$11.81M, a 773.49% decline from fiscal 2021.
  • Asensus Surgical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $1.75M, a 74.81% decline from fiscal 2020.
  • Asensus Surgical, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $6.96M.
Period endCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month
2024-06-30-$9.44M
10-Q · filed 2024-08-13
2024-03-31-$10.26M
10-Q · filed 2024-05-14
2023-12-31$11.27M
10-K · filed 2024-03-21
2023-09-30$15.81M
10-Q · filed 2023-11-14
2023-06-30$1.56M
10-Q · filed 2024-08-13
2023-03-31$12.41M
10-Q · filed 2024-05-14
2022-12-31-$11.81M
10-K · filed 2024-03-21
2022-09-30-$4.31M
10-Q · filed 2023-11-14
2022-06-30-$7.15M
10-Q · filed 2023-08-10
2022-03-31$6.72M
10-Q · filed 2023-05-11
2021-12-31$1.75M
10-K · filed 2023-03-02
2021-09-30$43.40M
10-Q · filed 2022-11-10
2021-06-30$140.59M
10-Q · filed 2022-08-08
2021-03-31$148.87M
10-Q · filed 2022-05-04
2020-12-31$6.96M
10-K · filed 2022-02-28
2020-09-30$10.55M
10-Q · filed 2021-11-03
2020-06-30$5.66M
10-Q · filed 2021-08-05
2020-03-31$12.17M
10-Q · filed 2021-05-11
2019-12-31-$11.08M
10-K · filed 2022-02-28
2019-09-30$1.15M
10-Q · filed 2020-11-05
2019-06-30$2.36M
10-Q · filed 2020-08-05
2019-03-31$4.47M
10-Q · filed 2020-05-15
2018-12-31-$75.95M
10-K · filed 2020-03-16
2018-09-30-$55.20M
10-Q · filed 2019-11-12
2018-06-30$887.00K
10-Q · filed 2019-08-08
2018-03-31-$3.19M
10-Q · filed 2019-05-09
2017-12-31$63.02M
10-K · filed 2019-02-27
2017-09-30-$3.72M
10-Q · filed 2018-11-08
2017-06-30$1.57M
10-Q · filed 2018-08-07
2017-03-31-$11.07M
10-Q · filed 2018-05-08
2016-12-31-$3.86M
10-K · filed 2019-02-27
2016-09-30$14.42M
10-Q · filed 2017-11-09
2016-06-30$26.45M
10-Q · filed 2017-08-02
2015-12-31$3.43M
10-K · filed 2018-03-08